1037 studies found for:    Open Studies | "Carcinoma, Bronchogenic"
Show Display Options
Rank Status Study
1 Recruiting SAS in Patients With Bronchial Carcinoma
Conditions: Sleep Apnea Syndrome;   Bronchial Carcinoma
Intervention: Device: sleep apnea screening with ApneaLinkTM
2 Recruiting Clinic Study of 18F-Al-NOTA-PRGD2 in Cancer Diagnostics
Conditions: Tumors;   Carcinoma, Bronchogenic;   Breast Carcinoma;   Cancer of Head and Neck;   Lymphoma, Malignant;   Soft Tissue Neoplasms
Intervention: Drug: 18F-Al-NOTA-PRGD2 PET/CT
3 Not yet recruiting Prevalence of Sleep-disordered Breathing in Patients With a Newly Diagnosed Non Small Cell Lung Cancer
Condition: Bronchial Cancer
Intervention: Device: With and without SDB
4 Unknown  Efficacy and Safety Study of Gefitinib in Squamous NSCLC Patients Who Failed First-Line Chemotherapy
Condition: Squamous Cell Carcinoma of Bronchus
Intervention: Drug: Gefitinib
5 Unknown  Study to Determine the Efficacy of Bendamustin in Patients With Recurrent Small Cell Lung Cancer (SCLC)
Condition: Recurrent Small Cell Lung Cancer
Intervention: Drug: Bendamustin/Ribomustin
6 Recruiting Comparison of Different Types of Surgery in Treating Patients With Early-stage Non-small Cell Lung Cancer
Conditions: Stage IA Non-small Cell Lung Cancer;   Adenocarcinoma of the Lung;   Squamous Cell Lung Cancer
Intervention:
7 Recruiting Phase I Trial of Afatinib (BIBW 2992) and Dasatinib in Non-small Cell Lung Cancer (NSCLC)
Conditions: Lung Cancer;   Non-small Cell Lung Cancer (NSCLC)
Interventions: Drug: Dasatinib - 1A;   Drug: Afatinib - 1A;   Drug: Dasatinib - 1B;   Drug: Afatinib - 1B
8 Not yet recruiting A Study of Atezolizumab (MPDL3280A) as First-line Monotherapy for Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC): Clinical Evaluation of Novel Blood-Based Diagnostics
Condition: Non-Small Cell Lung Cancer
Intervention: Drug: Atezolizumab
9 Recruiting A Positron Emission Tomography (PET) Imaging Agent [18F]-ODS2004436 as a Marker of EGFR Mutation in Subjects With NSCLC
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Other: Injection of [18F]-ODS2004436 radiotracer
10 Not yet recruiting Nivolumab and Plinabulin in Treating Patients With Stage IIIB-IV, Recurrent, or Metastatic Non-small Cell Lung Cancer
Conditions: Recurrent Non-Small Cell Lung Carcinoma;   Stage IIIB Non-Small Cell Lung Cancer;   Stage IV Non-Small Cell Lung Cancer
Interventions: Other: Laboratory Biomarker Analysis;   Biological: Nivolumab;   Drug: Plinabulin
11 Recruiting Combination of Cetuximab and NK Immunotherapy for Recurrent Non-small Cell Lung Cancer
Condition: Recurrent Non-small Cell Lung Cancer
Interventions: Drug: Cetuximab;   Biological: NK immunotherapy
12 Not yet recruiting DE-CT in Lung Cancer Proton Therapy
Condition: Non Small Cell Lung Cancer
Intervention: Procedure: DE-CT's and 4D-CT
13 Recruiting Clinical Study of Ganoderma Lucidum Spore Combined With Chemotherapy
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Ganoderma lucidum spore;   Drug: Placebo;   Drug: Chemotherapy
14 Recruiting Combination of Cryosurgery and NK Immunotherapy for Advanced Non-Small Cell Lung Cancer
Condition: Non-small Cell Lung Cancer Metastatic
Interventions: Device: Cryosurgery;   Biological: NK Immunotherapy
15 Not yet recruiting Improving Pulmonary Function Following Radiation Therapy
Condition: Non-Small Cell Lung Cancer
Interventions: Other: Laboratory Biomarker Analysis;   Radiation: Standard fractionation;   Radiation: Stereotactic Body Radiation Therapy (SBRT);   Procedure: Four Dimensional Computed Tomographic Imaging (4DCT)
16 Not yet recruiting Osimertinib (AZD9291) in First-line Locally Advanced or Metastatic NSCLC Patients With EGFR and EGFR T790M
Condition: Non-Small Cell Lung Cancer
Intervention: Drug: Osimertinib
17 Recruiting Intensity-modulated Radiotherapy (IMRT) With Simultaneous Integrated Boost (SIB) for Inoperable Non-small-cell Lung Cancer
Condition: Non-Small Cell Lung Cancer
Intervention: Radiation: IMRT + SIB + Chemotherapy
18 Not yet recruiting A Trial of CV301 in Combination With Nivolumab Versus Nivolumab in Subjects With Previously Treated Non-Small Cell Lung Cancer
Condition: Non-small Cell Lung Cancer (NSCLC)
Interventions: Biological: CV301;   Biological: nivolumab
19 Recruiting The Effect of Combined General/Regional Anesthesia on Cancer Recurrence in Patients Having Lung Cancer Resections
Condition: Non-small Cell Lung Cancer
Interventions: Drug: General anesthesia;   Drug: Combined general/epidural anesthesia
20 Recruiting CAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid Tumor
Conditions: Hepatocellular Carcinoma;   Non-small Cell Lung Cancer;   Pancreatic Carcinoma;   Triple-Negative Invasive Breast Carcinoma;   Malignant Glioma of Brain;   Colorectal Carcinoma;   Gastric Carcinoma
Intervention: Biological: anti-MUC1 CAR-pNK cells

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years